Patent · US Active

Inhibitors of HCV NS5A

US8877707B2 · kind B2 · utility

5Cited by
4References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 23, 2011
Grant dateNov 4, 2014
Priority date—
Expiry dateMay 23, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/7056
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.